• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

指状乳头状腺癌与HPV-42相关且BRAFV600E阴性:诊断实践的视角

Digital Papillary Adenocarcinoma Is HPV-42-Associated and BRAFV600E Negative: Perspectives for Diagnostic Practice.

作者信息

Dege Tassilo, Rütten Arno, Goebeler Matthias, Kneitz Hermann

机构信息

Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, 97080 Würzburg, Germany.

Dermatopathology Friedrichshafen, 88048 Friedrichshafen, Germany.

出版信息

Dermatopathology (Basel). 2024 Dec 9;11(4):348-353. doi: 10.3390/dermatopathology11040037.

DOI:10.3390/dermatopathology11040037
PMID:39727619
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11674806/
Abstract

Digital papillary adenocarcinoma (DPAC) is a rare, low-grade sweat gland carcinoma primarily found on the hands, fingers, or toes and predominantly affecting males. Distinguishing DPAC from benign sweat gland tumors can be challenging. We present the case of a 52-year-old patient with a progressive tumor on the finger initially misdiagnosed as a viral wart. Histological examination revealed a cytologically basophilic sweat gland tumor with tubular structures, papillary protrusions, and a characteristic immunohistochemical staining pattern for CK 7 and Actin. HPV-42 positivity and molecular analysis confirmed the diagnosis of DPAC. HPV-42 has been strongly associated with DPAC. Additionally, p16 positivity and BRAFV600E negativity were observed. These findings aid in the differential diagnosis of acral sweat gland tumors and guide clinical management, including with respect to the potential for recurrence and metastasis.

摘要

指状乳头状腺癌(DPAC)是一种罕见的低级别汗腺癌,主要发生于手部、手指或脚趾,且男性更为多见。将DPAC与良性汗腺肿瘤区分开来可能具有挑战性。我们报告一例52岁患者,其手指上有一进行性肿瘤,最初被误诊为病毒疣。组织学检查显示为一种细胞嗜碱性的汗腺肿瘤,具有管状结构、乳头状突起以及CK 7和肌动蛋白特征性免疫组化染色模式。HPV - 42阳性及分子分析确诊为DPAC。HPV - 42与DPAC密切相关。此外,观察到p16阳性和BRAFV600E阴性。这些发现有助于肢端汗腺肿瘤的鉴别诊断,并指导临床管理,包括复发和转移的可能性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b4a/11674806/36cde800c8cb/dermatopathology-11-00037-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b4a/11674806/ae3d0779863a/dermatopathology-11-00037-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b4a/11674806/f02d9ab228ac/dermatopathology-11-00037-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b4a/11674806/36cde800c8cb/dermatopathology-11-00037-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b4a/11674806/ae3d0779863a/dermatopathology-11-00037-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b4a/11674806/f02d9ab228ac/dermatopathology-11-00037-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b4a/11674806/36cde800c8cb/dermatopathology-11-00037-g003.jpg

相似文献

1
Digital Papillary Adenocarcinoma Is HPV-42-Associated and BRAFV600E Negative: Perspectives for Diagnostic Practice.指状乳头状腺癌与HPV-42相关且BRAFV600E阴性:诊断实践的视角
Dermatopathology (Basel). 2024 Dec 9;11(4):348-353. doi: 10.3390/dermatopathology11040037.
2
Association of HPV42 with digital papillary adenocarcinoma and the use of in situ hybridization for its distinction from acral hidradenoma and diagnosis at non-acral sites.HPV42 与指状突状汗管囊腺癌的相关性及其与肢端汗腺瘤的鉴别诊断和非肢端部位的原位杂交检测。
Mod Pathol. 2022 Oct;35(10):1405-1410. doi: 10.1038/s41379-022-01094-8. Epub 2022 May 10.
3
NUT Expression Is of Diagnostic Utility in the Distinction of Digital Papillary Carcinoma From Poroid Hidradenoma.NUT 表达在鉴别指状突状细胞癌与多孔性汗腺瘤中具有诊断效用。
Am J Dermatopathol. 2024 Feb 1;46(2):98-100. doi: 10.1097/DAD.0000000000002596. Epub 2023 Nov 14.
4
Value of Immunohistochemistry to Differentiate Digital Papillary Adenocarcinoma From Acral Hidradenoma With Papillary Structures.免疫组织化学在鉴别具有乳头状结构的肢端汗腺腺瘤与指状乳头状腺癌中的价值。
Am J Dermatopathol. 2022 Nov 1;44(11):843-845. doi: 10.1097/DAD.0000000000002291. Epub 2022 Sep 1.
5
Clinicopathologic Characterization of Hidradenoma on Acral Sites: A Diagnostic Pitfall With Digital Papillary Adenocarcinoma.肢端部位汗腺瘤的临床病理特征:与指(趾)部乳头状腺癌的鉴别诊断陷阱
Am J Surg Pathol. 2020 May;44(5):711-717. doi: 10.1097/PAS.0000000000001426.
6
Genomic and Transcriptomic Profiling of Digital Papillary Adenocarcinomas Reveals Alterations in Matrix Remodeling and Metabolic Genes.指状乳头状腺癌的基因组和转录组分析揭示了基质重塑和代谢基因的改变。
J Cutan Pathol. 2025 Apr;52(4):309-316. doi: 10.1111/cup.14782. Epub 2025 Jan 6.
7
Digital papillary adenocarcinoma: a case report.指状乳头状腺癌:一例报告
Hand Surg. 2006;11(1-2):51-3. doi: 10.1142/S0218810406003061.
8
"Apocrine Hidrocystoma and Cystadenoma"-like Tumor of the Digits or Toes: A Potential Diagnostic Pitfall of Digital Papillary Adenocarcinoma.指(趾)部“大汗腺汗管囊瘤和囊腺瘤”样肿瘤:数字型乳头状腺癌的潜在诊断陷阱
Am J Surg Pathol. 2016 Mar;40(3):410-8. doi: 10.1097/PAS.0000000000000547.
9
Ancillary immunohistochemical and molecular testing in the classification of cutaneous sweat gland/duct neoplasms: A validation study with emphasis on histomorphologic correlation and pathological diagnosis.皮肤汗腺/导管肿瘤分类中的辅助免疫组织化学和分子检测:重视组织形态学相关性和病理诊断的验证研究。
Hum Pathol. 2024 Aug;150:1-8. doi: 10.1016/j.humpath.2024.06.006. Epub 2024 Jun 12.
10
Digital Papillary Adenocarcinoma: The Detection of Low-Risk Human Papillomaviruses and the p.V600E Mutation in a Subset of Cases.指状乳头状腺癌:低风险人乳头瘤病毒的检测及部分病例中的p.V600E突变
Dermatopathology (Basel). 2024 Jun 28;11(3):177-183. doi: 10.3390/dermatopathology11030018.

本文引用的文献

1
Digital Papillary Adenocarcinoma: The Detection of Low-Risk Human Papillomaviruses and the p.V600E Mutation in a Subset of Cases.指状乳头状腺癌:低风险人乳头瘤病毒的检测及部分病例中的p.V600E突变
Dermatopathology (Basel). 2024 Jun 28;11(3):177-183. doi: 10.3390/dermatopathology11030018.
2
Ancillary immunohistochemical and molecular testing in the classification of cutaneous sweat gland/duct neoplasms: A validation study with emphasis on histomorphologic correlation and pathological diagnosis.皮肤汗腺/导管肿瘤分类中的辅助免疫组织化学和分子检测:重视组织形态学相关性和病理诊断的验证研究。
Hum Pathol. 2024 Aug;150:1-8. doi: 10.1016/j.humpath.2024.06.006. Epub 2024 Jun 12.
3
Unusual presentation of digital papillary adenocarcinoma in a sporotrichoid pattern.
呈孢子丝菌病样模式的指状乳头状腺癌的不寻常表现。
Indian J Dermatol Venereol Leprol. 2024 Jan 3:1-4. doi: 10.25259/IJDVL_932_2023.
4
Nectin-4 expression in a subset of cutaneous adnexal carcinomas: A potential target for therapy with enfortumab vedotin.Nectin-4 在皮肤附属器癌中的一部分亚型中表达:一种用恩福妥单抗治疗的潜在靶点。
J Cutan Pathol. 2024 May;51(5):360-367. doi: 10.1111/cup.14579. Epub 2024 Jan 10.
5
Digital Papillary Adenocarcinoma in Nonacral Skin: Clinicopathologic and Genetic Characterization of 5 Cases.非肢端皮肤的数字化乳头状腺癌:5 例的临床病理和遗传学特征。
Am J Surg Pathol. 2023 Oct 1;47(10):1077-1084. doi: 10.1097/PAS.0000000000002096. Epub 2023 Jul 31.
6
Acral BRAF-mutated tubular adenoma should be distinguished from HPV42-related digital papillary adenocarcinoma.肢端BRAF突变型管状腺瘤应与HPV42相关的指状乳头状腺癌相鉴别。
J Cutan Pathol. 2023 Jun;50(6):577-579. doi: 10.1111/cup.14430. Epub 2023 Apr 14.
7
Two distinct pathogenic pathways of digital papillary adenocarcinoma - BRAF mutation or low-risk HPV infection.指状乳头状腺癌的两种不同致病途径——BRAF突变或低风险人乳头瘤病毒感染。
J Cutan Pathol. 2023 Jun;50(6):568-576. doi: 10.1111/cup.14386. Epub 2023 Mar 8.
8
RG2-VLP: a Vaccine Designed to Broadly Protect against Anogenital and Skin Human Papillomaviruses Causing Human Cancer.RG2-VLP:一种旨在广泛预防导致人类癌症的肛门生殖器和皮肤人乳头瘤病毒的疫苗。
J Virol. 2022 Jul 13;96(13):e0056622. doi: 10.1128/jvi.00566-22. Epub 2022 Jun 15.
9
Association of HPV42 with digital papillary adenocarcinoma and the use of in situ hybridization for its distinction from acral hidradenoma and diagnosis at non-acral sites.HPV42 与指状突状汗管囊腺癌的相关性及其与肢端汗腺瘤的鉴别诊断和非肢端部位的原位杂交检测。
Mod Pathol. 2022 Oct;35(10):1405-1410. doi: 10.1038/s41379-022-01094-8. Epub 2022 May 10.
10
The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study.英国英格兰国家 HPV 疫苗接种计划对宫颈癌和 3 级宫颈上皮内瘤变发病率的影响:基于登记的观察性研究。
Lancet. 2021 Dec 4;398(10316):2084-2092. doi: 10.1016/S0140-6736(21)02178-4. Epub 2021 Nov 3.